SOLACI-SOCIME 2022 – Live Cases from Centro Médico Nacional: 20 de Noviembre, Mexico City

✔️ SOLACI-SOCIME 2022 – Live Cases from Centro Médico Nacional: 20 de Noviembre, Mexico City

✔️ SOLACI-SOCIME 2022 Scientific Session


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

LIVE CASE “VitaFlow” FROM “SANATORIO FINOCHIETTO” BA, ARGENTINA – SOLACI-SOCIME 2022

✔️ LIVE CASE “VitaFlow” FROM “SANATORIO FINOCHIETTO” BA, ARGENTINA - SOLACI-SOCIME 2022 ✔️ Video del SOLACI-SOCIME 2022

LIVE CASE “Pulmonar Valve” from Hospital Universitario Austral, BA, Argentina – SOLACI-SOCIME 2022

✔️ LIVE CASE “Pulmonar Valve” from “Hospital Universitario Austral, BA, Argentina - SOLACI-SOCIME 2022. Structural Room. ✔️ SOLACI-SOCIME 2022 Scientific Session.

SOLACI-SOCIME 2022: Live Cases from Centro Médico Nacional Siglo XXI, Mexico City

✔️ SOLACI-SOCIME 2022: Live Cases from Centro Médico Nacional Siglo XXI, Mexico City. ✔️ SOLACI-SOCIME 2022 Scientific Session. 

SOLACI-SOCIME 2022 – Live Cases from Centro Médico Nacional: La Raza, Mexico City

✔️ Live Cases from Centro Médico Nacional: La Raza, Mexico City ✔️ Sponsored cases by Orbus & Terumo ✔️ SOLACI-SOCIME 2022 Scientific Sessions 👨‍🏫 Contents: 00:15 -...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...